Article ; Online: Daptomycin: a comparison of two intravenous formulations.
Drug design, development and therapy
2018 Volume 12, Page(s) 1953–1958
Abstract: Daptomycin is a cyclic lipopeptide antibacterial agent with potent bactericidal activity against a broad range of Gram-positive organisms. In 2003, daptomycin for injection received approval from the US Food and Drug Administration (FDA) for the ... ...
| Abstract | Daptomycin is a cyclic lipopeptide antibacterial agent with potent bactericidal activity against a broad range of Gram-positive organisms. In 2003, daptomycin for injection received approval from the US Food and Drug Administration (FDA) for the treatment of patients with complicated skin and skin structure infections (cSSSIs); in 2006, it was approved for the treatment of patients with |
|---|---|
| MeSH term(s) | Administration, Intravenous ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/pharmacology ; Daptomycin/administration & dosage ; Daptomycin/pharmacology ; Drug Compounding ; Humans ; Microbial Sensitivity Tests ; Staphylococcal Infections/drug therapy ; Staphylococcal Infections/microbiology ; Staphylococcus aureus/drug effects ; United States ; United States Food and Drug Administration |
| Chemical Substances | Anti-Bacterial Agents ; Daptomycin (NWQ5N31VKK) |
| Language | English |
| Publishing date | 2018-06-29 |
| Publishing country | New Zealand |
| Document type | Comparative Study ; Journal Article ; Review |
| ZDB-ID | 2451346-5 |
| ISSN | 1177-8881 ; 1177-8881 |
| ISSN (online) | 1177-8881 |
| ISSN | 1177-8881 |
| DOI | 10.2147/DDDT.S167010 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.